Member Info for researcher1

construction is already super busy and about to go into overdrive. I can see April 20 to April 21 revenues actually rising!

Libero is talking nonsense (he must have missed the 22p opportunity?)- there is no way the company can undercut CDR's investment at 25p, and any takeover would IMO likely be north of 30p. There are now long term price targets of 200p out there, so plenty of buying pressure, and revenue will be at above-normal levels come February. Company far stronger financially than many peers, and a new CEO with everything to prove! Even if the news is moderate next time, he'll be spinning it from now on. What's not to like?

It will be interesting to hear what AN has to say on this - $4 equivalent will I think take 3 years, so your split scenario is definitely on the cards...

is it ridiculously quiet on here today, or is there an LSE glitch? Did anyone manage to buy some in the 21s?? I tried but they wouldn't let me...

Longlad, it will take at least 3 months I believe - the 6 month estimate takes account of the urgent C-19 vaccine submissions...
However, there is other research being done in the meantime that will lift the SP in anticipation of FDA approval. I hope today when the US wakes up, the big investors there will top up to the60p at which they bought in - that price would be my prediction for close of play today.

I'm assuming it is the £20 at H&B (so a £60,000) order....

does anyone have the latest price for 3000 boxes of Slimbiome?

Wonderful that they hit their Covid-revised target, and during that period received 2 further independent endorsements. The submission is a monster, but it reads as if the Q process has taken away any uncertainty. 6 months sounds reasonable for the time the FDA might take, especially given the quantity of C-19 vaccines to trawl through at present. I also like that in the information there is clearly a pipeline of new applications. Well done AN and team - let's hope they easily achieve the intended X3.7 share increase over the next three years - so about £2, though I recall the US investors want to wait for £5!

I would guess they would have to land an offer above director purchases and the 83M investment, but not necessarily as high as the open offer - so we should be looking at 26 to 29p - but these things can come in higher to ensure complete acquiescence..

I would wait at least until it floats back up to 25 -26p if I were you.... before Xmas...

broker ratings are good and firm - HOLD is absolutely the right call - all the insulation revenue is yet to come...

due to the depressed tone of the RNS I sold all my 25p shares at 25p yesterday, so today I'm buying them all back at 22.9p (another 40K just purchased) to bring my average down to 26.5p. I'm predicting break-even by Spring, and 20% rise in a year.

today's problem is OPTI's announcement suggesting a US listing that may require a lower holding of SBTX - they would be crazy to crash the SP to achieve that however - better find an ii who wants in at a set price - circa 22p would be my guess, as a compromise between the low that would occur if they dumped everything and the high that would occur if an institution began accumulating that many shares...

figures as expected, even a fraction better, so I can see this returning near to where it started by tomorrow evening. It looks like a year until full recovery however, which means the short-termers want out. Wait for the insulation incentive impact - SIG specialism... 2021 growth will be a sight for sore eyes...

does anyone understand why Jupiter are selling at this juncture? seems crazy to me...

wow, beautiful re-entry price. will fill my boots today.....

hope everyone loaded up at 25p?

last chance sub 30p?

so our previous discussion on metastasis proved pertinent! The market is deliberately under-reacting, which suits me this morning, just sold my Zoo holding @60p for 100% profit....

feels to me like there's going to be some mayhem first thing.....